top of page

35+ YEARS IN MEDICAL DEVICE | PHARMACEUTICAL | BIOTECHNOLOGY | DIAGNOSTICS

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

Search

GT Medical Technologies Raises $100M in Oversubscribed Series E Financing to Expand Brain Tumor Treatment

1 hour ago
1 min read

Tempe, AZ, June 9, 2026 (PR Newswire) -- GT Medical Technologies has completed an oversubscribed $100 million Series E equity financing to support commercialization of its treatment for patients with operable brain tumors. The proceeds will be used to expand market adoption, scale manufacturing, and advance additional clinical and commercial initiatives. The financing strengthens the company's position as it broadens access to its targeted radiation therapy platform.

Read full article here.

Recent Posts

Repligen to Acquire BioLife Solutions in $1.5B Deal to Expand Bioprocessing Portfolio

Waltham, MA, July 22, 2026 (Reuters) -- Repligen has agreed to acquire BioLife Solutions in a transaction valued at approximately $1.5 billion. The acquisition expands Repligen’s portfolio of biopro

Roche Appoints Dan Malarek as President and CEO of Roche Diagnostics North America

Indianapolis, IN, July 20, 2026 (PR Newswire) -- Roche Diagnostics North America has appointed Dan Malarek as president and chief executive officer. Malarek will lead the company’s North American di

Sarepta Therapeutics Appoints Michael Severino as Chief Executive Officer

Cambridge, MA, July 27, 2026 (Business Wire) -- Sarepta Therapeutics has appointed Michael F. Severino as chief executive officer. Severino will lead the company’s strategic direction as it advances

Comments

Life Science Headlines

Repligen to Acquire BioLife Solutions in $1.5B Deal to Expand Bioprocessing Portfolio

Roche Appoints Dan Malarek as President and CEO of Roche Diagnostics North America

GT Medical Technologies Raises $100M in Oversubscribed Series E Financing to Expand Brain Tumor Treatment

Sarepta Therapeutics Appoints Michael Severino as Chief Executive Officer

Lilly to Acquire Atai Beckley in Up to $1.6B Deal to Expand Mental Health Pipeline

EQT to Acquire TachoSil Biosurgery Business from Corza Medical

ARS Pharmaceuticals Appoints Richard Lowenthal as CEO Following Leadership Transition

Novartis to Acquire Myricx Bio in Up to $2.9B Deal to Expand ADC Cancer Pipeline

ARK Surgical Appoints Joseph B. Labruzzo as President and CEO of U.S. Operations

Vertex to Acquire Crinetics in $10B Deal to Expand Endocrinology Portfolio

bottom of page